The metabolism of alicyclic amines to reactive iminium ion intermediates

No abstract is available for this paper.

• Publication year

  1994

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  1994-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF03188923PMID 7867663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissociation of covalent protein adduct formation from oxidative injury in cultured hepatocytes exposed to cocaine.

  1994cited by this paper
• The enzymology of the in–vitro oxidation of prolintane to oxoprolintane

  1993cited by this paper
• Preliminary evidence for the formation of reactive intermediates during the in vitro metabolism of minor tobacco alkaloids

  1993cited by this paper
• The binding and regioselectivity of reaction of (R)- and (S)-nicotine with cytochrome P-450cam: parallel experimental and theoretical studies

  1993cited by this paper
• The roles of cytochrome P450 in nicotine metabolism

  1993cited by this paper
• Application of chemical cytochrome P-450 model systems to studies on drug metabolism. IV. Mechanism of piperidine metabolism pathways via an iminium intermediate.

  1991cited by this paper
• Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.

  1991cited by this paper
• Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite.

  1991cited by this paper
• A nuclear magnetic resonance study of sparteine delta metabolite structure.

  1991cited by this paper
• Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation.

  1991cited by this paper
• Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite.

  1991cited by this paper
• The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung.

  1990cited by this paper
• Enzymatic oxidation of xenobiotic chemicals.

  1990cited by this paper
• Rabbit nasal cytochrome P-450 NMa has high activity as a nicotine oxidase.

  1990cited by this paper
• Metabolic studies on phencyclidine: characterization of a phencyclidine iminium ion metabolite.

  1988cited by this paper
• Metabolism-dependent covalent binding of (S)-[5-3H]nicotine to liver and lung microsomal macromolecules.

  1988cited by this paper
• Regio- and stereochemical studies on the alpha-carbon oxidation of (S)-nicotine by cytochrome P-450 model systems.

  1988influential reference
• Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-nicotine delta 1'(5')-iminium species.

  1987cited by this paper
• Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes.

  1987cited by this paper
• Characterization of hamster liver nicotine metabolism. I. Relative rates of microsomal C and N oxidation.

  1986cited by this paper
• Cytochrome P-450-dependent nicotine oxidation by liver microsomes of guinea pigs. Immunochemical evidence with antibody against phenobarbital-inducible cytochrome P-450.

  1985cited by this paper
• RING-CHAIN TAUTOMERISM OF PSEUDOOXYNICOTINE AND SOME OTHER IMINIUM COMPOUNDS

  1984cited by this paper
• Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal protein.

  1982cited by this paper
• Participation of cytochrome P-450 in nicotine oxidation.

  1982cited by this paper
• The metabolism of nicotine-Δ1′(5′)-iminium ion,in vivo andin vitro

  1982cited by this paper
• The metabolism of nicotine-delta 1'(5')-iminium ion, in vivo and in vitro.

  1982cited by this paper
• Metabolic formation of iminium species: metabolism of phencyclidine.

  1982cited by this paper
• Nicotine delta 1 "(5)' iminium ion: a reactive intermediate in nicotine metabolism.

  1981cited by this paper
• The tautomeric structures of 5-hydroxycotinine, a secondary mammalian metabolite of nicotine

  1981cited by this paper
• Nicotine delta 1 "(5)' iminium ion: a reactive intermediate in nicotine metabolism.

  1981cited by this paper
• Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of 1-benzylpyrrolidine.

  1980cited by this paper
• The enzyme “aldehyde oxidase” is an iminium oxidase. Reaction with nicotine Δ1′(5′) iminium ion

  1979cited by this paper
• Metabolic oxidation of nicotine to chemically reactive intermediates.

  1979cited by this paper
• The enzyme "aldehyde oxidase" is an iminium oxidase. Reaction with nicotine delta 1'(5') iminium ion.

  1979cited by this paper
• Synthesis, Structure and Stability of Nicotine Delta1'(5') Iminium Ion, an Intermediary Metabolite of Nicotine.

  1979influential reference
• METABOLIC N-DEMETHYLATION OF NICOTINE. TRAPPING OF A REACTIVE IMINIUM SPECIES WITH CYANIDE ION

  1976cited by this paper
• Metabolic N-demethylation of nicotine. Trapping of a reactive iminium species with cyanide ion.

  1976cited by this paper
• Letter: Nicotine chemistry. 5'-cyanonicotine.

  1975cited by this paper
• The metabolism of tobacco alkaloids

  1975cited by this paper
• Enzymatic oxidation of nicotine to nicotine 1'(5') iminium ion. A newly discovered intermediate in the metabolism of nicotine.

  1973cited by this paper
• Selective inhibition of alternative oxidative pathways of nicotine metabolism.

  1971cited by this paper
• Modification of nicotine toxicity by pretreatment with different drugs.

  1969cited by this paper
• The cholinergic properties of some amino‐acid esters and amides

  1968cited by this paper
• Enzymatic pathway for the formation of cotinine, a major metabolite of nicotine in rabbit liver.

  1960cited by this paper

• Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling

  2025cites this paper
• Design and synthesis of new quinazolinone derivatives: investigation of antimicrobial and biofilm inhibition effects

  2024cites this paper
• Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity.

  2024cites this paper
• Utilizing mechanistic organic chemistry training to study drug metabolism in preclinical drug discovery/development

  2023cites this paper
• In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics

  2021cites this paper
• Cytochrome P450-Mediated Drug Bioactivation Assay: An Untargeted High Resolution Accurate Mass LC/MS Assay

  2021cites this paper
• Liquid Chromatography‐Mass Spectrometry (LC‐MS) Quantification of Reactive Metabolites

  2021cites this paper
• Electrochemical N-demethylation of tropane alkaloids

  2020cites this paper
• Designing Around Structural Alerts in Drug Discovery.

  2020cites this paper
• Discovery and Evaluation of Enantiopure 9H-pyrimido[4,5-b]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability

  2020cites this paper
• Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

  2019cites this paper
• Aldehyde oxidase and its role as a drug metabolizing enzyme.

  2019cites this paper
• LC-ESI-MS/MS identification and characterization of ponatinib in vivo phase I and phase II metabolites.

  2018cites this paper
• Liabilities Associated with the Formation of "Hard" Electrophiles in Reactive Metabolite Trapping Screens.

  2017cites this paper
• In vitro activity of dihydropyrazole derivatives against Candida species

  2017cites this paper
• Studies on the Metabolism of Nitrogen Compounds by Prof J. W. Gorrod.

  2017cites this paper
• Structure-metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines.

  2017cites this paper
• Comparison of the Reactivity of Trapping Reagents toward Electrophiles: Cysteine Derivatives Can Be Bifunctional Trapping Reagents.

  2015cites this paper
• Detecting reactive drug metabolites for reducing the potential for drug toxicity

  2015cites this paper
• Design, synthesis and antibacterial potential of 5-(benzo[d][1,3]dioxol-5-yl)-3-tert-butyl-1-substituted-4,5-dihydropyrazoles

  2014cites this paper
• Contribution of Artifacts to N-Methylated Piperazine Cyanide Adduct Formation In Vitro from N-Alkyl Piperazine Analogs

  2013cites this paper
• Complementation of biotransformations with chemical C-H oxidation: copper-catalyzed oxidation of tertiary amines in complex pharmaceuticals.

  2013cites this paper
• High-Resolution Mass Spectrometry Elucidates Metabonate (False Metabolite) Formation from Alkylamine Drugs during In Vitro Metabolite Profiling

  2012cites this paper
• Mass spectrometric tools for cell and tissue studies.

  2012cites this paper
• Technical Challenges and Recent Advances of Implementing Comprehensive ADMET Tools in Drug Discovery

  2012cites this paper
• Microbial decyanation of 1-benzylpyrrolidine-2,5-dicarbonitrile. Mechanistic investigations

  2011cites this paper
• D-Isomer of gly-tyr-pro-cys-pro-his-pro peptide: a novel and sensitive in vitro trapping agent to detect reactive metabolites by electrospray mass spectrometry.

  2011cites this paper
• Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship.

  2011cites this paper
• Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.

  2011cites this paper
• Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design

  2011cites this paper
• Strategies for the Detection of Reactive Intermediates in Drug Discovery and Development

  2010cites this paper
• Metabolism, Pharmacokinetics, and Excretion of the 5-Hydroxytryptamine1B Receptor Antagonist Elzasonan in Humans

  2010cites this paper
• Metabolite Identification Strategies and Procedures

  2009cites this paper
• Comprehensive assessment of ADMET risks in drug discovery.

  2009cites this paper
• Bioactivation of Drugs by Cytochromes P450 : New Tools and Concepts for the Characterization of Reactive Metabolites of Drugs

  2009cites this paper
• A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide.

  2009cites this paper
• Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug

  2008cites this paper
• Role of Bioactivation in Idiosyncratic Drug Toxicity: Structure–Toxicity Relationships

  2008cites this paper
• Liquid chromatography-mass spectrometry for detection and characterization of DNA biomarkers and reactive metabolites

  2008cites this paper
• A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

  2008cites this paper
• Role of Biotransformation Studies in Minimizing Metabolism-Related Liabilities in Drug Discovery

  2008cites this paper
• New analytical strategies in studying drug metabolism

  2007cites this paper
• Screening for reactive intermediates and toxicity assessment in drug discovery.

  2006cites this paper
• Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

  2005cites this paper
• Minimising the potential for metabolic activation in drug discovery

  2005cites this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cites this paper
• Amino effect on the protonation of beta-aminoacrylonitrile.

  2005cites this paper
• Metabolism and Disposition Kinetics of Nicotine

  2005cites this paper
• Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites.

  2005cites this paper
• Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

  2004cites this paper
• A novel P450-catalyzed transformation of the 2,2,6,6-tetramethyl piperidine moiety to a 2,2-dimethyl pyrrolidine in human liver microsomes: characterization by high resolution quadrupole-time-of-flight mass spectrometry and 1H-NMR.

  2003cites this paper
• Biotransformation of cyclizine in greyhounds. 1: identification and analysis of cyclizine and some basic metabolites in canine urine by gas chromatography-mass spectrometry

  2002cites this paper
• Stereoselective hydroxylation of nonpeptidic HIV protease inhibitors by CYP2D6.

  1999cites this paper
• Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.

  1998cites this paper
• Metabolism of (−)-(S)-nicotine by guinea pig and rat brain: identification of cotinine

  1997cites this paper
• Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.

  1997cites this paper
• Metabolism of (−)-(S)-nicotine in the isolated perfused rabbit lung

  1997cites this paper
• In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.

  1996cites this paper
• Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity.

  1996cites this paper
• Pharmacokinetics and metabolism of N-(2-hydroxyethyl)-2,5-[14C]-pyrrolidine (HEP, Epolamine) in male healthy volunteers

  1996cites this paper
• The Failure of Substrate pKa to Influence the Microsomal Formation of Amides from N‐Benzylamines: the Microsomal Metabolism of N‐Benzyl Pyrrolidine, N‐Benzyl Carbazole and N‐Acetyl‐N‐benzyl‐4‐methylaniline

  1996cites this paper